𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Cytologic diagnosis of low-grade papillary urothelial neoplasms (low malignant potential and low-grade carcinoma) in the context of the 1998 WHO/ISUP classification

✍ Scribed by Richard E. Whisnant; Sheldon I. Bastacky; N. Paul Ohori


Publisher
John Wiley and Sons
Year
2003
Tongue
English
Weight
179 KB
Volume
28
Category
Article
ISSN
8755-1039

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

The 1998 World Health Organization/International Society of Urological Pathology (WHO/ISUP) classification of urothelial neoplasms introduced a category called papillary neoplasm of low malignant potential (LMP) and separated it from low‐grade papillary urothelial carcinoma (LGPUC), which was thought to yield abnormal cells in cytology specimens. The objective of our study was to evaluate the effectiveness of urine cytology in diagnosing these lesions. Eighty‐six paired transurethral surgical biopsy and corresponding urine cytology specimens representing the spectrum of urothelial papillary lesions were examined. Consensus diagnosis on each biopsy was made, and the distribution was as follows: 16 benign urothelium, 27 LMP, 28 LGPUC, and 15 high‐grade papillary urothelial carcinoma (HGPUC). This was followed by a blinded independent review of the urine cytology specimens by three observers. Each cytology case was marked as negative, atypical, suspicious, or positive for malignant cells by using previously published cytologic criteria. When the negative and atypical diagnoses were grouped together as “benign” and the suspicious and malignant diagnoses as “malignant,” the detection rate of “malignancy” of the lesions was as follows: LMP, 37%; LGPUC, 25%; and HGPUC, 53%. The false positive rate was 6%, and the positive predictive value (PPV) was 94%. Detection rates of cells that were at least “atypical” were as follows: LMP, 74%; LGPUC, 79%; and HGPUC, 100%. While most of the LMP and LGPUC cases yielded cells that were at least “atypical,” there was no significant difference in the distribution of cytologic diagnoses for LMP and LGPUC cases (P > 0.05). Urine cytology in the context of the 1998 WHO/ISUP classification appears to be useful as a screening tool but does not appear to discriminate LMP effectively from LGPUC. Diagn. Cytopathol. 2003;28:186–190. © 2003 Wiley‐Liss, Inc.


📜 SIMILAR VOLUMES


Cytokeratin expression patterns in low-g
✍ David Ramos; Samuel Navarro; Rafael Villamón; Manuel Gil-Salom; Antonio Llombart 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 351 KB

## Abstract ## BACKGROUND The differential expression patterns of cytokeratin 20 (CK20) and 34βE12 antigen in low‐grade papillary urothelial tumors of the bladder are discussed. ## METHODS A retrospective study of 120 patients with low‐grade papillary bladder tumors (45 neoplasms of low malignan

Proliferative activity is the most signi
✍ Achille Pich; Luigi Chiusa; Andrea Formiconi; Diego Galliano; Paola Bortolin; Al 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 83 KB

## Background: Recurrence of transitional cell carcinoma of the bladder cannot be predicted accurately by traditional criteria alone. this study examined the value of cell proliferative activity, morphometry, and expression of p53, c-erbb-2, and bcl-2 oncogenes in predicting recurrence of superfici